• Keine Ergebnisse gefunden

Table S-5. Distribution of patients with localised prostate cancer across risk statusISUP gradegroupingRisk statusProportion of patients with localisedprostate cancer with this risk statusSource

N/A
N/A
Protected

Academic year: 2022

Aktie "Table S-5. Distribution of patients with localised prostate cancer across risk statusISUP gradegroupingRisk statusProportion of patients with localisedprostate cancer with this risk statusSource"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Table S-5. Distribution of patients with localised prostate cancer across risk status ISUP grade

grouping

Risk status Proportion of patients with localised

prostate cancer with this risk status

Source 1 Low risk (PSA <10 ng/ml; Gleason score

<7; and cT1 to 2a)

31% Survey

of local experts 2 to 3 Intermediate risk (PSA 10 to 20 ng/ml; or

Gleason score =7; or cT2b)

44%

4 to 5 High risk (PSA >20 ng/ml; or Gleason score

>7; or above cT2c)

25%

Abbreviations: cT, clinical cancer tumor (T) staging, ISUP, International Society of Urology Pathology; GS, Gleason score; PSA, prostate-specific antigen

Referenzen

ÄHNLICHE DOKUMENTE

We showed that class discovery analysis based on our gene expression profiling of 82 breast tissue specimens as well as some reference samples like cell lines identifies four

The goal of our study presented here was to examine the predictive value of MAPT, TOPO IIa, and HER-2 mRNA expression in breast cancer patients who received neoadjuvant

The cumulative incidence of OM (grade 1–4) was 97.3% in the selenium and 100% in placebo group (p value: 0.79), and difference in the mean serum selenium level at the end of

Total patients in RISE represents patients in RISE, aged 18 years and older, at least 2 visits with &gt;= 30 days apart during the study period with

This study addresses the following questions in a cohort of patients with oral squamous cell cancer who were treated at the department of oral and maxillofacial surgery at the

High-risk factors and prognosis analysis of endo- metrial hyperplasia complicated with endometrial cancer.. Travaglino A, Raffone A, Saccone G, Insabato L, Mollo A, De Placido G,

The search string (Supplemental File A) that was executed in the databases PubMed, Embase and Cinahl up to December 2020, included patients diagnosed with colon or rectal cancer

In the study presented in this work, we aimed to assess the prevalence of sarcopenia, defined as low skeletal mass and muscle strength, and its impact on 1-year mortality in